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ER Stress Response Failure and 




Dynamic metabolic changes occur in the liver during the transition between 
fasting and eating, which is mainly mediated by insulin, a hormone to promote 
anabolism and suppress catabolism. In obesity and diabetes, insulin resistance is 
induced via various mechanisms, and among them is endoplasmic reticulum (ER) 
stress. We recently reported that eating induces transient ER stress and consequent 
ER stress response in the liver. During eating, expression of Sdf2l1, an ER-resident 
molecule involved in ER stress-associated degradation, is induced as a part of ER 
stress response. XBP-1s regulates expression of Sdf2l1 at the transcription level, 
and Sdf2l1 terminates eating-induced ER stress in the liver, consequently regulat-
ing glucose and lipid metabolism. In obesity and diabetes, however, ER stress 
response is impaired, partly because insulin-mediated translocation of XBP-1s to 
the nucleus is suppressed, which results in further excessive ER stress. Induction of 
Sdf2l1 by XBP-1s is highly down-regulated, but restoration of Sdf2l1 ameliorates 
glucose intolerance and fatty liver. In diabetic patients, hepatic insulin resistance 
induces enhanced ER stress and ER stress response failure in the liver, which in 
turn promote hepatic fibrosis and contribute to the development of steatohepatitis 
comorbid with diabetes.
Keywords: liver, insulin signaling, insulin resistance, diabetes mellitus,  
feeding, endoplasmic reticulum stress, stromal cell-derived factor 2 like 1,  
X-box binding protein 1, fatty liver
1. Introduction
Organisms need to take in nutrients from outside for biological activities and 
survival, and deprivation of nutrients is a heavy burden for organisms. However, 
various responses are induced even during eating, in order to cope with the rapid 
influx of nutrients. The liver plays pivotal roles in the maintenance of systemic 
nutritional homeostasis depending on the feeding conditions, and dynamic changes 
are induced during the transition between fasting and feeding, or eating. During 
fasting, the liver releases glucose by glycogenolysis and gluconeogenesis, and ketone 
bodies by fatty acid oxidation, while during feeding, it stores excessive nutrition 
derived from food by synthesizing glycogen and fatty acids. Conversely, dysregula-
tion of these processes may lead to metabolic disorders, such as insulin resistance 
and fatty liver disease [1].
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In this chapter, we are going to discuss physiological and patho-physiological 
aspects of stress response during eating, by reviewing the insulin signaling cascade 
first, then endoplasmic reticulum (ER) stress, which is becoming an emerging 
player in the regulation of metabolism in the liver, and finally the roles of ER stress 
response failure in the development of steatohepatitis comorbid with diabetes.
2. Insulin action and downstream molecules
Insulin is the major regulator of metabolism which is secreted from pancreatic 
beta cells, and it promotes anabolism and suppresses catabolism in the targeted 
tissues including the liver [2–5].
In the early 1980s, tyrosine kinase activity of insulin receptor was first reported [6], 
and the whole cascade of the signaling has been uncovered in the past 40 years. In brief, 
in the presence of insulin, IR (insulin receptor) phosphorylates IRSs (insulin receptor 
substrates). Among the isoforms of IRSs, IRS-1 and IRS-2 are the major ones, and they 
activate two main signaling pathways: the PI3K (phosphatidylinositol 3-kinase)-Akt/
PKB (protein kinase B) pathway and the Ras–MAPK (mitogen-activated protein 
kinase) pathway. The former is mainly responsible for metabolic actions of insulin, and 
the latter mainly regulates cell growth and differentiation [5] (Figure 1).
In obesity and diabetes, however, the insulin signaling cascade is impaired 
by various mechanisms despite normal or high concentrations of insulin, which 
is called insulin resistance. It is generally thought that serine/threonine kinases, 
such as PKC (protein kinase C), JNK (c-jun N-terminal kinases), IKKβ (inhibi-
tor of nuclear factor kappa-B kinase subunit β), and PP2A (protein phosphatase 
2A), are activated in obesity via lipotoxicity, inflammation, hyperglycemia, 
mitochondrial dysfunction and subsequent oxidative stress, and ER stress, which 
is reviewed in the following subsection. Serine/threonine kinases thus activated in 
Figure 1. 
Insulin signaling pathways (adapted from [7]).
3
ER Stress Response Failure and Steatohepatitis Comorbid with Diabetes
DOI: http://dx.doi.org/10.5772/intechopen.100054
turn causes inhibitory phosphorylation of insulin receptor, IRSs, and Akt [8, 9]. 
Hyperinsulinemia also down-regulates expression of IRS-2 via suppression of a 
transcription factor, FoxO1 (forkhead box protein O1), in the liver, contributing to 
the induction of insulin resistance [10, 11].
3. ER stress and ER stress response
3.1 Overview of ER stress response cascade
The ER is an organelle involved in synthesis of secretory proteins and membrane 
proteins. In the ER, unfolded proteins, immediately after translation and entrance 
into the organelle, are matured through modification, such as folding, formation of 
disulfide bonds, and initiation of glycosylation. Under ER stress, in which unfolded 
or misfolded proteins accumulate in the ER due to increased protein synthesis or 
chaperone dysfunction, various kinds of ER stress response are induced, and some 
of them are cytoprotective and others are cytotoxic [12].
Among the numerous molecules involved in ER stress response, also called 
UPR (unfolded protein response), BiP (binding immunoglobulin protein), also 
known as GRP78 (glucose-regulated protein 78), is a chaperone with an ATPase 
domain, which plays pivotal roles in ER stress response mainly via interaction 
with ERdjs (ER-localized DnaJ family members) [13]. BiP binds to unfolded or 
misfolded proteins in the ER and promotes folding by consuming ATP. Moreover, 
BiP binds to ER stress sensor molecules, IRE1-alpha (inositol-requiring enzyme 
1 alpha), ATF6 (activating transcription factor 6), and PERK (PKR-like endo-
plasmic reticulum kinase), and prevent them from activation. Under ER stress, 
however, BiP is mainly engaged in increased unfolded or misfolded proteins and 
dissociates from the ER stress sensors, resulting in phosphorylation of IRE1-alpha 
and PERK, as well as cleavage of ATF6 followed by nuclear translocation to the 
nucleus [12, 14].
It is well known that phosphorylated IRE1-alpha splices Xbp1 (X-box binding 
protein 1) mRNA [15]. XBP-1 s protein induces chaperones, including BiP and 
XBP-1 s itself, as a transcription factor by binding to motifs called ERSEs (ER stress 
response elements). XBP-1 s also promotes ERAD (ER-associated degradation) by 
binding to motifs called UPRs (UPR response elements), and attenuates translation 
via mRNA degradation. nATF6 (nuclear ATF6) also works as a transcription factor to 
induce chaperones by binding to ERSEs. Phosphorylated PERK phosphorylates eIF2 
alpha (eukaryotic initiation factor-2 alpha), which suppresses translation and lowers 
protein loading. Overall, these responses are protective against ER stress, by suppress-
ing protein synthesis, inducing chaperones, and promoting protein degradation.
Sustained ER stress is, however, known to induce rather cytotoxic responses. 
Phosphorylated IRE1-alpha activates JNK, resulting in inflammation, oxidative 
stress and apoptosis. Phosphorylated eIF-2 alpha also induces CHOP (CCAAT-
enhancer-binding protein homologous protein), a transcription factor involved in 
apoptosis, as well as oxidative stress and inflammation, via another transcription 
factor, ATF4 [12, 14].
It is difficult to detect unfolded/misfolded proteins in the ER of mammals 
directly, but activation of the upstream ER stress sensors is considered to be a good 
marker to reflect ER stress. Activation or expression of the downstream molecules 
involved in ER stress response are also frequently used as ER stress markers, but we 
are going to discuss the discrepancy between the upstream sensors and the down-
stream effectors, which we call ER stress response failure, in subsections below 
(Figure 2).
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3.2 ER stress and metabolic disorders
In the field of metabolism, ER stress causes metabolic disorders in various 
tissues and, in the liver, ER stress is considered to be involved in the development 
of insulin resistance and fatty liver disease [16]. It was first reported that ER stress 
markers were enhanced in the liver of mouse models of obesity and diabetes  
[17, 18]. Systemic Xbp1 knockout mice are a well-known model of impaired ER 
stress response, which shows elevated ER stress, impaired insulin signaling, 
and glucose intolerance [17]. Moreover, administration of chemical chaperones 
improves not only insulin resistance and hyperglycemia but also fatty liver [19]. 
Similarly, suppressed activation of the PERK branch of the ER stress response 
cascade, by dephosphorylation of eIF2 alpha, also improves hepatosteatosis as well 
as glucose tolerance [20]. Thus generally, impaired responses to chronic ER stress 
or excessive chronic ER stress in the liver are considered to result in hepatic insulin 
resistance and fatty liver disease, although these phenotypes were not necessarily 
replicated in other models [21, 22], and XBP-1 s protein was also reported to up-
regulate lipogenic genes [23].
However, some years later, ER stress response was reported to be suppressed, 
contrary to the earlier reports, and a controversy was thus raised about whether ER 
stress and ER stress response are enhanced or suppressed in obesity and diabetes. 
Activity of nATF6 is suppressed in the liver of mouse models of obesity and diabetes 
[24]. Moreover, binding with p85, one of the key downstream molecules of insulin 
signaling, is required for XBP-1 s protein to be translocated to the nucleus and exert 
its activity as a transcription factor in the liver. In model mice of obesity and diabetes, 
however, insulin-mediated nuclear translocation of XBP-1 s protein is impaired due to 
insulin resistance [25, 26]. A similar insulin signaling-mediated nuclear translocation 
of XBP-1 s protein was recently reported in other tissues as well [27]. Interestingly, 
XBP-1 s protein regulates gluconeogenesis rather directly, via ubiquitination and con-
sequent proteasome-mediated degradation of FoxO1, a transcription factor involved 
in the induction of gluconeogenic enzymes in the liver [28] (Figure 3).
Taken together, insulin signaling appears not only to promote protein synthesis, 
but also to be involved in quality control of synthesized proteins. Moreover, XBP-1 s 
is a multi-talented molecule which is closely associated with regulation of not only 
ER stress response but also glucose and lipid metabolism.
Figure 2. 
Schematic description of the cascade of ER stress response.
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3.3 ER stress in the liver and diseases in humans
In humans, some ER stress markers are known to be affected by insulin resis-
tance and nonalcoholic steatohepatitis (NASH). NASH is associated with phos-
phorylation of JNK and lower XBP-1 s protein levels [29]. Expression of sXBP1 and 
BiP mRNA is not correlated with insulin resistance [30], but is lowered by gastric 
bypass surgery [31]. We and colleagues previously reported that IRS-1 expression 
in the liver is negatively correlated with fibrosis [32], suggesting the protective role 
of insulin signaling against the development of NASH. These reports, however, did 
not distinguish ER stress and ER stress response or NASH in diabetic patients and 
NASH in non-diabetic patients.
4. Roles of Sdf2l1 in the regulation of ER stress and metabolism
4.1 Feeding induces ER stress response in the liver
Recently, we reported that a chaperone, Sdf2l1 (stromal cell-derived factor 2 
like 1), plays crucial roles in the termination of feeding-induced ER stress in the 
liver and consequently in the maintenance of glucose and lipid metabolism. We 
propose that ER stress response failure, including suppressed induction of Sdf2l1 by 
XBP-1 s, is a key link between insulin resistance and steatohepatitis comorbid with 
diabetes [33].
Our first finding was that ER stress is induced transiently during feeding in 
the liver, based on the microarray data using murine liver samples comparing the 
fasting and refeeding conditions in the public domain [34]. We were particularly 
interested in Sdf2l1 among the genes highly up-regulated by refeeding, which 
showed a large increase in expression. Sdf2l1 had been reported to be induced 
by ER stress [35], and to function as a component of the ER chaperone complex 
including BiP [36–39]. Besides, the orthologs in yeast, Pmt1p and Pmt2p, are 
O-mannosyltransferases and known to enhance ubiquitination of unfolded proteins 
as an initiation of ERAD [40–42]. Little is known, however, of roles of Sdf2l1 in the 
regulation of glucose and lipid metabolism.
Figure 3. 
XBP-1s protein in the regulation of glucose metabolism: insulin-mediated nuclear translocation and regulation 
of gluconeogenesis.
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Indeed, the cascade of ER stress response is activated during feeding in the 
liver: phosphorylation, expression, and nuclear localization of the downstream ER 
stress marker proteins, as well as expression of ER stress marker genes, are elevated 
(Figure 4) [33]. 
Therefore, although major attention had been focused on the chronic and patho-
physiological aspects of ER stress and ER stress response in the field of metabolism, 
transient ER stress and consequent ER stress response (just for a few hours) are 
induced in the liver by the physiological stimulation of feeding, or eating, even in 
lean nondiabetic mice. Such induction of ER stress during feeding is attributed to 
protein intake and insulin signaling [33], both of which reach the liver during feed-
ing and promote protein synthesis [3, 5, 43].
4.2 Regulation and function of Sdf2l1 as an ER stress response
We explored the regulatory mechanism underlying the induction of Sdf2l1, 
and found that Sdf2l1, as well as BiP, is regulated by transcription factors, XBP-1 s 
and nATF6 by not only chemically induced ER stress but also refeeding in the liver. 
XBP-1 s and nATF6 binds to an 11-bp motif responsible for the induction of Sdf2l1 
upstream in the promotor region [33], which is similar to ERSEs targeted by XBP-1 s 
and nATF6 with nuclear factor Y as a co-factor [12].
We further explored the function of Sdf2l1 in ER stress response, and found that 
knocking down of Sdf2l1 leads to accumulation of exogenously expressed Ins2C96Y, 
a mutant insulin found in Akita mice as a model of misfolded protein degraded 
by ERAD [44], showing that Sdf2l1 modulates ER stress via regulating ERAD. 
Although Sdf2l1 had been known to interact with BiP [36–38], knocking down 
of BiP did not affect such accumulation, suggesting the existence of some other 
counterparts of Sdf2l1. Then, based on the results of mass spectrometric analysis of 
microsomal fractions, we focused on TMED10 (transmembrane emp24-like traf-
ficking protein 10), a membrane protein known to regulate protein transportation 
from the ER to the Golgi apparatus [45]. Indeed, knocking down of either Sdf2l1 or 
TMED10 results in increased accumulation of misfolded protein and enhanced ER 
stress, showing that TMED10 is the major counterpart of Sdf2l1 to regulate ERAD 
and consequently ER stress. Interestingly, in yeast, p24, the ortholog of TMED10, 
interacts with Pmt1/2p and promotes ER export of unfolded proteins for ERAD 
Figure 4. 
Schematic description of the ER stress response cascade in the liver during feeding (adapted from [33]).
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[41], and now the orthologs in mice turns out to interact with each other to regulate 
ERAD to cope with ER stress [33].
4.3 Sdf2l1 modulates ER stress response and metabolism
We then assessed the physiological and pathophysiological roles of Sdf2l1 in 
vivo. Adenovirus-mediated knocking down and knocking out of Sdf2l1 specifi-
cally in the liver of adult mice both result in enhanced ER stress during refeeding, 
impaired insulin signaling in the liver, systemic insulin resistance, glucose intoler-
ance, and markedly increased triglyceride contents in the liver.
Thus, impaired induction of Sdf2l1 results in sustained ER stress, leading to 
insulin resistance and increased triglyceride contents, even with a normal-chow 
diet, indicating that dysregulation of ER stress by suppression of Sdf2l1 is a causal 
factor of metabolic disorders. Together with the previous reports showing that 
ablation of key molecules in ER stress response links impaired glucose and lipid 
metabolism in mice fed on a high-fat diet or a high-fructose diet [17, 21, 22], our 
data strongly suggest that an appropriate transient response to ER stress is induced 
physiologically during feeding, or eating, and terminated by Sdf2l1, and that this 
process may be important for the maintenance of nutrient homeostasis [33].
4.4 Impaired ER stress response in obesity and diabetes
Then we explored the roles of ER stress response in the development of insulin 
resistance and fatty liver in obesity and diabetes. Figure 5 summarizes the changes 
in the ER stress response cascade observed in a mouse model, db/db mice. The ER 
stress sensors are activated, suggesting excessive ER stress in the liver possibly 
due to hyperinsulinemia and over-nutrition. However, downstream molecules of 
the cascade that are expected to cope with ER stress are suppressed in expression 
or insufficiently activated. Among those, Sdf2l1 is highly down-regulated, and 
chromatin immunoprecipitation (ChIP) assay revealed that the down-regulation of 
Sdf2l1 is attributed to suppressed activity of XBP-1 s, not of ATF6 [33], presumably 
due to the decreased insulin action to promote the translocation of XBP-1 s to the 
nucleus by binding to p85 [25, 26].
We call it ER stress ‘response failure’, which results in further excessive ER 
stress, forming a vicious cycle. It is known that activation of the ER stress sensors 
Figure 5. 
Schematic description of the ER stress response cascade in the liver in obesity and diabetes (adapted from [33]).
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is attenuated during prolonged ER stress, resulting in only insufficient activa-
tion or induction of downstream molecules involved in ER stress response [46]. 
Suppression of the whole cascade of ER stress response might be called ER stress 
‘sensing failure’, which draws clear contrast with ER stress ‘response failure’ [33], 
and this novel concept is now gaining publicity [47].
In order to rescue ER stress response failure, over-expression of the upstream 
XBP-1 s protein does not show full recovery of expression of downstream chap-
erones and consequently insulin resistance. On the other hand, restoration of 
suppressed expression of a downstream chaperone, Sdf2l1, does improve insulin 
signaling in the liver, systemic insulin resistance, glucose intolerance, and fatty 
liver. Moreover, larger beneficial effects come from co-restoration of Sdf2l1 and 
BiP, and in accordance with the findings in vitro, we conclude that Sdf2l1 improves 
insulin sensitivity independently of BiP, at least in part [33].
4.5 ER stress and ER stress response in humans
Lastly, we assessed whether impaired ER stress response could be associated 
with progression of human diseases by examining data from male subjects with 
suspected NAFLD (nonalcoholic fatty liver disease) who underwent liver biopsy 
after oral glucose tolerance test early in the morning, partially mimicking the fed 
state. In diabetic subjects, expression of the upstream sXBP1 mRNA is elevated 
in subjects with insulin resistance, but the downstream-to-upstream ratio, the 
SDF2L1/sXBP1 ratio, is lower in subjects with insulin resistance. Similarly, in 
those with diabetes, sXBP1 is positively, but the SDF2L1/sXBP1 ratio is nega-
tively, correlated with stage or fibrosis of NASH. These changes and correlations 
are not observed in nondiabetic subjects, showing that impaired response to 
ER stress, as well as enhanced ER stress, are associated with the progression of 
insulin resistance and steatohepatitis, which is unique to patients with diabetes 
(Table 1) [33].
In the ‘two-hit hypothesis’ on the development of NASH, accumulation of 
lipids or steatosis is promoted by the first ‘hit’, whereas the further progression 
to steatohepatitis requires the presence of the second ‘hit(s)’ [48]. Given that 
ER stress is one of the major potential second hits (and others are inflammation, 
oxidative stress, autophagy failure, and mitochondria dysfunction), our data show 
that not only ER stress but also ER stress response failure serve as the second hits 
in the progression from NAFLD to NASH. Moreover, insulin resistance is one of 
the major potential first hits, but diabetes is a disease in which insulin resistance 
fails to be compensated and insulin action is impaired. Decompensated insulin 
resistance leads to insufficient induction of ER stress response via suppressed 
nuclear translocation of XBP-1 s protein to the nucleus [25, 26]. Thus, our data 
show that insulin-mediated nuclear translocation of XBP-1 s protein links the 
first and second hits, and the SDF2L1/sXBP1 ratio is a promising biomarker [33]. 
It is also implied that mechanisms underlying NASH in diabetic patients and 
those underlying NASH in non-diabetic patients could be different and should be 




sXBP1 mRNA (upstream) Elevated Positively correlated
SDF2L1/sXBP1 mRNA ratio (downstream-to-upstream ratio) Lowered Negatively correlated
Table 1. 
Summary of ER stress and ER stress response in diabetic patients (adapted from [33]).
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These findings could account for the therapeutic effects of insulin sensitizers 
against not only diabetes but also NASH [49], although insulin signaling itself pro-
motes anabolism of lipids [1]. Moreover, it may be useful to identify the effectors 
downstream of Sdf2l1 to regulate ERAD more directly, when we consider develop-
ment of more effective drugs for these diseases by shutting down the vicious cycle 
due to ER stress response failure [33].
Figure 6. 
Schematic description of ER stress and ER stress response in the ‘two-hit hypothesis’ on the development of 
NASH comorbid with diabetes (adapted from [33]).
Figure 7. 
Schematic description of our hypothesis on physiological and pathophysiological roles of Sdf2l1-centered ER 
stress response in the liver [33].
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Recently, a novel concept of metabolic dysfunction-associated fatty liver 
disease, or MAFLD, was proposed [50, 51], a broader concept than NAFLD, which 
was proposed in the 1980s [52]. The roles of insulin resistance are considered to be 
increasingly important [53], and ER stress response failure is expected to contribute 
also to the development of steatohepatitis in patients with diabetes and MAFLD.
Most recently, Fib-4 index, a marker of hepatic fibrosis, was reported to be a 
good prognostic factor for the development of hepatocellular carcinoma in diabetic 
patients, in a nationwide survey in Japan [54]. Given that our data show that ER 
stress and ER stress response failure are associated with hepatic fibrosis, improve-
ment of ER stress and ER stress response failure might be protective against carci-
nogenesis as well.
Overall, feeding, or eating, induces physiological and transient ER stress in the 
liver, and induced Sdf2l1 appropriately terminates ER stress, in cooperation with 
TMED10, and contributes to normal glucose and lipid metabolism. In obesity and 
diabetes, impaired ER stress termination signals, including the down-regulation of 
Sdf2l1 that is caused by decreased insulin signaling, sustains ER stress and exacerbates 
insulin resistance, creating a vicious cycle. Thus, Sdf2l1 is expected to be a therapeutic 
target and a sensitive biomarker in obesity-associated diseases (Figure 7).
5. Conclusions
We reveal that eating induces physiological and transient ER stress and ER stress 
response, including up-regulation of Sdf2l1, in the liver. In obesity and diabetes, 
however, ER stress response failure, including down-regulation of Sdf2l1, results in 
sustained ER stress, which links insulin resistance and the development of steato-
hepatitis comorbid with diabetes.
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